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Abstract
Diphtheria toxin A (DTA), a segment of the diphtheria toxin (tox), inhibits protein synthesis in cells. When released
from a cell, DTA is nontoxic and cannot enter other cells independently without the help of diphtheria toxin B.
In this study, we artificially synthesized the DTA gene sequence and cloned it into pEGFP-N1 to generate the
recombinant vector pEGFP-N1-DTA. This recombinant vector was then transfected into 293T cells to observe
the effect of DTA protein expression on enhanced green fluorescent protein (EGFP) protein expression and the
proliferation of 293T cells. After 48 h, high levels of EGFP expression were seen in control pEGFP-N1-transfected
cells, whereas very low levels were seen in cells transfected with pEGFP-N1-DTA. Reverse transcription polymerase
chain reaction confirmed the expression of the DTA gene in cells transfected with pEGFP-N1-DTA. Further,
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay revealed a significant difference
in cell proliferation between the control group and the pEGFP-N1-DTA-transfected group. Using the expression
of EGFP expression as an indicator, this study revealed that DTA expression can inhibit intracellular protein
synthesis and cell proliferation.
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Introduction
Diphtheria toxin, a 58-kDa exotoxin secreted by Coryne-
bacterium diphtheriae transduced by a beta bacterio-
phage, can inactivate the ADP-ribosylation of elongation
factor 2 (EF2), resulting in the inhibition of protein syn-
thesis and cell death. Diphtheria toxin can be cleaved
by trypsin into fragment A (193 aa) and fragment B
(342 aa). Diphtheria toxin fragment A (DTA) is a
21-kDa protein that is responsible for the inactivation of
EF2, causing inhibition of protein synthesis. Fragment B
is a 37-kDa protein that can bind to cell-surface recep-
tors and deliver DTA into cells [1,2]. Studies have shown
that the toxicity of the DTA protein is very high; a mol-
ecule of DTA is able to cause cell death is non-toxic in
the extracellular form [3,4]. Because of its toxicity and
specific molecular structure, DTA has been widely used
to kill specific cells in targeted tumor treatment, such
as for human breast cancer and lung cancer [5-10].
The current study provides a new strategy to directly
and indirectly verify the effect of the DTA protein on
intracellular protein synthesis and cell proliferation.
Materials and methods
Materials
The pEGFP-N1 vector (Clontech) and 293T cells were
available in our laboratory. The KOD FX polymerase was
obtained from Toyobo. T4 DNA ligase, restriction
enzymes, and DL2000 were obtained from Takara. Agarose
and kits related to DNA were purchased from OMEGA.
3-(4,5-Dimethyl-2-thiazoly) 2,5-diphenyl-2-tetrazolium bro-
mide (MTT) was purchased from Fluka. Dulbecco’s
modified Eagle medium (DMEM/F12 [Invitrogen]), fetal
bovine serum (FBS; Hyclone), Lipofectamine 2000, and
the reverse transcription polymerase chain reaction
(RT-PCR) kit were purchased from Invitrogen. Other
reagents were all pure preparations of analytical grade.
DTA gene sequence
The DTA amino acid sequence includes residues 1–193
of the diphtheria toxin. Therefore, the coding sequence
of diphtheria toxin (GenBank accession no.: 2650491) was
obtained from the National Center for Biotechnology
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Information (NCBI) and first 600 bp was synthesized by
Qinglanbio [11]. The DTA sequence was cloned into the
pUC-19 vector and verified by nucleotide sequencing




The pEGFP-N1-DTA plasmid was obtained by poly-
merase chain reaction (PCR) using pUC-19-DTA as a
template and the BglII-DTA forward (5'-GAAGATCT
CATGGTGAGCAGAAAACTGTTTGCGTC-3') and the
EcoRI-DTA reverse (5'-GGAATTCGTTGGCCACGTT
TTCCACGG-3') primers, to obtain DTA cDNA and
insert it into the multiple cloning site (MCS) of the
pEGFP-N1 plasmid. The resulting pEGFP-N1-DTA
plasmid contained DTA in the same open reading frame
(ORF) as EGFP and expressed the DTA-enhanced green
fluorescent protein (EGFP) fusion protein under the
control of the cytomegalovirus (CMV) promoter. For
the PCR, the reaction mixture was heated to 94°C for an
initial 5 min and then amplified by denaturing at 94°C
for 30 s, annealing at 60°C for 30 s, and extending at
72°C for 1 min, for a total of 35 cycles, with a final
extension at 72°C for 10 min.
Cell transfection
The 293T cells were maintained in DMEM/F12 medium
supplemented with 10% fetal bovine serum, and 100 U/mL
penicillin/streptomycin, and cultured in 37°C and 5%
CO2. When the cell cultures achieved >85% conflu-
ence, the 293T cells were removed by trypsinization
treatment, washed in phosphate-buffered saline (PBS).
The 293T cells were cultured in 24-well cell plates at
a density of 5.0 × 104 cells/well, and at approximately
75% confluence, cells were transfected with plasmids
(1 μg/well) using Lipofectamine 2000 (2 μL/well).
After 24 and 48 h, the expression of EGFP was detected
by fluorescence microscopy.
RT-PCR
Cells from the three groups (experimental, positive
control, and negative control) were collected 48 h post-
transfection, and total RNA was extracted. RNA iso-
lation and RT-PCR were performed according to the
manufacturers’ instructions.
Western blot analysis
First, 293T cells were transfected with pEGFP-N1 in the
control group and pEGFP-N1-DTA in the experimental
group. The same numbers of cells were collected
respectively from these two groups 48 h post-transfection.
Second, cells from the two groups were lysed respectively
in cell lysis buffer (P0013, Beyotime) supplemented with
phenylmethanesulfonyl fluoride for 15 min. Lysed cells
were centrifuged at 4°C, 14000×g supernatants were col-
lected for western blotting using 15 μL protein super-
natants and subjected sodium dodecyl-polyacrylamide
gel electrophoresis (SDS-PAGE) and transferred to an
immobilion-p transfer membrane (Millipore) and blocked
with 5% non-fat milk in tris-buffered saline containing
tween20 (TBST; 50 mM Tris base, pH 7.5, 150 mM NaCl,
and 0.1%(w/v) Tween 20). The membranes were incu-
bated with affinity-purified GFP-tag antibodies (1:4000
dilution, Abmayt) at 4°C overnight. The membranes
were washed three times with TBST and incubated with
goat anti-mouse IgG (1:2000) for 1–2 h at room tempe-
rature. Bands were visualized using the ECL western blot-
ting analysis system (Proteinsimple). The membranes
were washed with antibody eluent (glycine, 0.025M,
sodium dodecyl sulfate, 0.05M, pH 2.0), and treated with
anti-β-actin antibody (1:2000, Abmayt).
MTT assay
The 293T cells cultured in 96-well cell plates were trans-
fected and incubated for 24 or 48 h. Supernatants were
removed, 100 μL DMEM and 20 μL MTT (5 mg/mL)
were added in the absence of light to each well, and the
cells were further incubated. After 4 h, the 96-well plate
was centrifuged at 20°C and 425×g. The supernatant was
then removed using filter paper, 150 μL dimethylsulfox-
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Figure 1 Electrophoretic analysis of the pEGFP-N1-DTA
construct. Lane 1, DNA marker (5 kb); lane 2, pEGFP-N1 sequence
after digestion with BglII and EcoRI ; lane 3, DTA sequence after
digestion with BglII and EcoRI; lane 4, pEGFP-N1 plasmid; lane 5,
pEGFP-N1-DTA plasmid.
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shaken at 80 rpm for 15 min. Subsequently, the absorb-
ance at 490 nm was measured for each well, including
blanks, using a microplate reader.
DTA toxicity assay
Cells were transfected, as previously described, with
pEGFP-N1-DTA in the experimental group or pEGFP-
N1 for the control group. On the third and fifth
days post-transfection, the 293T cells were seeded into
12- and 6-well plates, respectively, and EGFP expression
and cell proliferation were assayed.
Statistics analysis
In MTT assay experiment, each group had three wells,
and the date value of each group was the average one of
three wells. Data was processed by SAS 8.1 (SAS Insti-
tute Inc., Cary, NC) statistical software. Significance was
declared at P ≤ 0.05.
Results
Construction of pEGFP-N1-DTA plasmid
Under ultraviolet light, EGFP protein emits green fluor-
escence that can be directly observed. Therefore, inhib-
ition of EGFP protein expression by DTA can be easily
and directly verified. In the pEGFP-N1 vector, the MCS
is located between the CMV promoter and the EGFP
coding sequence, and genes without stop codons cloned
into the MCS will be expressed as fusion proteins with
the N-terminus of EGFP if they are in the same reading
frame as EGFP. We cloned the DTA coding sequence
into the MCS in the same ORF as EGFP, generating a
plasmid, pEGFP-N1-DTA.
Figure 1 shows the electrophoretic separation of
restriction enzyme (BglII and EcoRI)-digested DTA
(600 bp) and pEGFP-N1 plasmid, the original pEGFP-
N1 plasmid, and the pEGFP-N1-DTA plasmid. Figure 2
shows the electrophoretic separation of the DTA and
parent pEGFP-N1 fragments following digestion of the
new construct by BglII and EcoRI. These results verify
that the pEGFP-N1-DTA vector (Figure 3) has been
successfully constructed.
EGFP expression assay and RT-PCR
Three conditions were tested in this experiment. The
experimental group and the positive control group
consisted of 293T cells transfected with pEGFP-N1-DTA
and pEGFP-N1, respectively, and the third group was
the negative control, which was incubated with complete
medium alone. Fluorescence microscopy showed high
expression levels of the EGFP protein in positive control
293T cells at 48 h post-transfection; however, very low-
level expression was observed in the experimental group
(Figure 3). No expression of EGFP was observed in the
negative control group (Figure 4). Figure 5 shows that
RT-PCR detected DTA expression in only the experi-










Figure 2 Electrophoretic analysis of pEGFP-N1-DTA digested
with two enzymes with BglII and EcoRI. Lane 1, DNA marker
(5 kb); lane 2, pEGFP-N1 fragment (top band) and DTA fragment
(bottom band).
Figure 3 Plasmid vector maps of pEGFP-N1 and pEGFP-N1-DTA. A) Main elements of pEGFP-N1-DTA. The CMV promoter drives the
expression of the DTA coding sequence and EGFP coding sequences in the same ORF. B) Main elements of pEGFP-N1. The CMV promoter
drives EGFP gene expression only.
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control groups. Western blot analysis confirmed that
the expression level of DTA-EGFP fusion protein in the
experimental group was lower than EGFP in positive
control. Moreover, the expression of β-actin in the
experimental group was also less than that found in the
positive control group. These data show that the expres-
sion of DTA inhibits the expression of EGFP, confirming
the effect of DTA.
Cell proliferation assay
Since DTA has been previously shown to inactivate the
ADP-ribosylation of EF2, it is likely to play a negative
role in cell proliferation. This study was carried out to
determine the effect of DTA expression on cell prolifera-
tion. The 293T cells, however, grow very fast, and split-
ting transfected cells into a new plate will lead to
inaccurate data, thus, we assayed cell proliferation at
24 and 48 h after transfection. Three treatments were
analyzed in this experiment: the experimental group, in
which the 293T cells were transfected with the pEGFP-
N1-DTA plasmid; the negative control group, that were
transfected with cell culture medium alone; and the
positive control group, in which cells were transfected with
pEFGP-N1. Figure 6 shows that at 24 h post-transfection,
the fluorescence intensity was significant different between
the transfected and negative control groups (P < 0.01).
At 48 h post-transfection, the fluorescence intensity be-
tween the transfected group and the negative and control
groups were significantly different (p < 0.05). On the other
hand, the differences between the negative and control
groups at 24 and 48 h were not statistically significant
(p > 0.05) indicating that the Lipofectamine 2000 had no
effect on our experimental observations. This experiment
showed that the DTA protein is toxic to cells and signifi-
cantly affects cell proliferation.
Toxicity of DTA
To further investigate the cytotoxicity of the DTA pro-
tein, we first cultured 293T cells in 24-well plates and
were then transfected with pEGFP-N1-DTA or pEGFP-
N1. The cells were then cultured in 12-well plates on
day 3 post-transfection, and in 6-well plates on day 5
post-transfection. Consistent with our previous observa-
tions, Figure 7 shows that at 24 h post-transfection,
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Figure 4 Transfection of the pEGFP-N1 vector and the pEGFP-N1-DTA vector into 293T cells. A) Transfection of pEGFP-N1 into 293T cells:
high EGFP expression at 48 h post-transfection. B) Transfection of pEGFP-N1-DTA into 293T cells: low levels of EGFP expression. A1 and B1,
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Figure 5 RT-PCR for transcription of genes. A) Agarose gel electrophoresis analysis of RT-PCR amplicons. Lane 1, DNA marker; lane 2, cells
transfected with pEGFP-N1; 3, cell transfected with pEGFP-N1-DTA; expression of DTA was seen only in the second group, and not in the first.
Actb was used as an internal control. B) Western blot analysis of cell extracts using anti-GFP and anti-β-actin antibodies. Lane 1, control group
transfected with pEGFP-N1; lane 2, experimental group transfected with pEGFP-N1-DTA. EGFP protein was detected in control group, and the
DTA-EGFP fusion protein in experimental group. The expression level of DTA-EGFP fusion protein was lower than EGFP, and the expression
of β-actin in experimental group was less than that in control group.
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the expression level of EGFP was much lower in cells
transfected with pEGFP-N1-DTA than in control cells.
Figure 8 shows that at 6 days post-transfection, the
number of cells expressing EGFP was low in the group
transfected with pEGFP-N1-DT but larger in the control
group. In addition, the cell density was also lower in the
former group than the latter. This experiment further
confirmed the toxicity of the DTA protein to cells and
its ability to inhibit cell proliferation.
Discussion
The toxicity of the DTA protein is very high, where a
single molecule is able to cause cell death [3]. Because of
its high toxicity, DTA has been widely used in targeted
tumor treatment and for generating animal models.
Our data show that the DTA protein can inhibit intra-
cellular protein expression and is toxic to cells, thereby
affecting cell proliferation. Because C. diphtheriae can
infect humans, we synthesized the DTA coding sequence
by artificial synthesis rather than from the bacterium.
Under excitation by UV light, EGFP emits visible
green fluorescence. Therefore, our experimental design
involved using the DTA protein to inhibit EGFP protein
synthesis in order to directly verify DTA protein func-
tion. Consistent with our hypothesis, our results showed
that after transfecting 293T cells with pEGFP-N1-DTA,
the level of EGFP expression was very low compared
with EGFP expression in control cells. Moreover, the
MTT assay was used to investigate the effect of DTA on
cell proliferation. Since Lipofectamine 2000 is toxic to
cells, we added a Lipo2000 control group to this experi-
ment. The present study showed that the difference in
cell proliferation between the Lipo2000 group and the
control group was not significant, demonstrating the
negligible effect of Lipofectamine 2000 on proliferation.
Further, the difference between cell survival in the
experimental group and the two control groups at 48 h
post-transfection was significant, but not more signifi-
cant than that seen at 24 h.
In the DTA toxicity assay, we initially cultured 293T
cells in 24-well plates and then transfected with pEGFP-
N1-DTA or pEGFP-N1. The 293T cells proliferate very
fast and need sufficient space to grow; additionally, the
expression of EGFP may cause death in a small number
of cells, which will affect the growth of other cells.
Therefore, when 293T cells reached 85% confluence, the
cells were split into 12-well plates and then 6-well plates
on the third and fifth day post-transfection, respectively.
On the sixth day, we found that the density of the cells




Figure 6 Cell proliferation assay. The optical density at 490 nm
is represented on the y-axis and the time after transfection on the
x-axis. Bars labeled with the same letter did not show significant
differences (p > 0.05); bars labeled with different and successive
letters differed significantly (0.01 < p < 0.05); bars labeled with





Figure 7 Transfection of 293T cells with pEGFP-N1 and pEGFP-N1-DTA vectors for 24 h. A) High EGFP expression was seen for
pEGFP-N1-transfected 293T cells. B) Lower EGFP expression levels was seen for pEGFP-N1-DTA-transfected cells at 24 h post-transfection;
A1 and B1, images taken under white light; A2 and B2, images taken under UV light; A3 and B3, merged pictures. Magnification, 200×.
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in the experimental group was less than that found in
the control group, confirming that the DTA protein
inhibited 293T cell proliferation. Moreover, few cells
were found to express EGFP protein in the experimental
group, whereas many cells produced EGFP in the con-
trol group. This experiment further demonstrated the
toxicity of the DTA protein and its inhibitory effect
on cell growth.
Based on its function and characteristics, DTA has
been widely used in tumor treatment, gene functional
studies, and in the generation of animal models, among
other applications [5-10]. In tumor treatment, the DTA
gene was cloned into the tetracycline recombinant viral
vector and A549 cells were inoculated subcutaneously
into nude mice. When the A549 tumor grew to 352 mg,
viral supernatant containing the DTA gene was injected
into the tumor resulting in resolution of the tumor [5].
With regard to gene functional studies and the gener-
ation of animal models, the lacZ coding sequence con-
taining loxP at both terminals was inserted into the
DTA coding sequence downstream of the ATG codon.
The floxed lacZ-DTA sequence was then targeted into
the location of the ROSA26 gene to generate a R26:
LacZ/DTA mouse model, which has been used to delete
specific cells in vivo, such as pyramidal neurons, oligo-
dendrocytes, B cells, and hepatocytes [7]. Researchers
have attempted to verify the function of cardiac muscle
cells in cardiac arrhythmia using myosin heavy chain α
(MHCα) to promote DTA gene expression and created a
transgenic mouse model [12]. In all, the DTA gene has
been widely used, and the results the current study can
provide a basis for future research. In 2009, Wu et al.
[13] discovered stem cells in the adult ovary, which was
a challenge contrary to existing knowledge. However,
there are still many scientists who do not accept this
because when these stem cells are replaced in mouse
ovaries treated with busulfan, not all of the recipient
mice were able to give birth to offspring. Researchers
can now make use of the DTA gene to specifically delete
oocytes in mice, and use this mouse model as the recipi-
ent without the need for chemical treatment, and the
resulting birth rate may provide a convincing answer to
resolve the argument of whether the cells from the ovary
are stem cells.
This study has directly verified the effect of the DTA
gene on intracellular protein synthesis and cell prolifera-
tion, and can be regarded as the basis for subsequent
research. It is believed that the DTA gene will be applied
to future research studies because of these effects.
In addition, the toxicity of the DTA protein to cancer
cells may be not only due to inhibition of protein
synthesis, but may also arise because of the induction of
cell apoptosis [5,14]. However, this problem is outside
the scope of the present study and will be investigated in
future studies.
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Figure 8 Transfection of 293T cells with pEGFP-N1 vector (A) and pEGFP-N1-DTA vector (B) at six days post-transfection. Few cells
emitting green light were observed in the group transfected with pEGFP-N1-DTA, whereas many were seen in the control group; the cell density
in the second group was less than that in the first group; A1 and B1, images taken under white light; A2 and B2, images taken under UV light;
A3 and B3, merged pictures. Magnification, 200×.
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